| Pharmaceutical active ingredients: |
| IbuprofenIbuprofen Lysine |
| Available forms, composition and doses of Ibufabra: |
| N / A |
| Ibufabra medical category: |
| Human:Nonsteroidal anti-inflammatory drugs (NSAIDs) |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C01EB16 - IbuprofenG02CC01 - IbuprofenM01AE01 - IbuprofenM02AA13 - Ibuprofen |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Fabra Laboratorios |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Saridon N | Ibuprofen Sodium Dihydrate | Roche; Bayer Schering Pharma |
| Saridon N Forte | Ibuprofen Sodium Dihydrate | Roche; Bayer Schering Pharma |
| Niofen | Ibuprofen; Ibuprofen Hydrochloride | Recalcine Laboratorios |
| Dolormin | Ibuprofen; Ibuprofen Lysine | Woelm Pharma; Janssen |
| Dolormin fur Kinder Ibuprofensaft | Ibuprofen; Ibuprofen Lysine | Woelm Pharma |
| Ibupirac | Ibuprofen; Ibuprofen Lysine | Pfizer; Instituto Sanitas |
| Ibupirac Forte | Ibuprofen; Ibuprofen Lysine | Pfizer; Instituto Sanitas |
| Ibupirac LC | Ibuprofen; Ibuprofen Lysine | Pfizer; Instituto Sanitas |
| Ibuprof | Ibuprofen; Ibuprofen Lysine | CT-Arzneimittel |
| Ibuprof Retard | Ibuprofen; Ibuprofen Lysine | CT-Arzneimittel |